Advertising Disclaimer
PEDIATRICS Vol. 93 No. 2 February 1994, pp. 205-210
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strauss, R. E.
Right arrow Articles by Valacer, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strauss, R. E.
Right arrow Articles by Valacer, D. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Aminophylline Therapy Does Not Improve Outcome and Increases Adverse Effects in Children Hospitalized With Acute Asthmatic Exacerbations

Raphael E. Strauss MD1, David L. Wertheim MD1, Vincent R. Bonagura MD1, , David J. Valacer MD1

1 Allergy and Immunology Division, Long Island Jewish Medical Center, New Hyde Park, NY

Objective. To evaluate the effects of aminophylline (Am) in children hospitalized with asthma.

Methods. Prospective, randomized, double-blind, placebo-controlled trial. Subjects were children between the ages of 5 and 18 years admitted for asthma exacerbation to either a tertiary care children's hospital or an innercity general hospital in New York. Exclusion criteria were admission to the intensive care unit, initial theophylline level > 5 µg/dL, or the presence of other systemic disorders. All patients received nebulized albuterol therapy and intravenous glucocorticosteroids in standardized doses. Thirty-one patients were randomized to receive either an Am bolus followed by continuous Am infusion or placebo (P) bolus and infusion. The outcome variables were: duration of hospitalization, percent of predicted peak expiratory flow rates recorded at 12-hour intervals, number of albuterol treatments required, and adverse effects.

Results. There were no significant differences at study entry in age, sex, race, number of previous hospital admissions, prior medications used, clinical symptom scores, or initial peak flow rates for the two groups. For 26 patients who completed this study, 15 patients in the P group were hospitalized for a mean duration of 2.33 ± 1.3 days, whereas 11 patients in the Am group required 2.58 ± 1.5 days. There were no significant differences between the two groups for hospital days, peak flow rates at any time interval, or amount of albuterol therapy required (P > .2). In the Am group, 6 of the 14 patients who entered the study experienced significant adverse effects consisting of nausea, emesis, headache, abdominal pain, and palpitations. Only 1 of 17 patients in the P group had an adverse effect (P <. 05).

Conclusions. There is no benefit and considerable risk of adverse effects associated with the use of Am in hospitalized asthmatic children.

Submitted on June 10, 1993
Accepted on September 24, 1993


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 ThoraxHome page
G Roberts, D Newsom, K Gomez, A Raffles, S Saglani, J Begent, P Lachman, K Sloper, R Buchdahl, and A Habel
Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial
Thorax, April 1, 2003; 58(4): 306 - 310.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. S. Ream, L. L. Loftis, G. M. Albers, B. A. Becker, R. E. Lynch, and R. B. Mink
Efficacy of IV Theophylline in Children With Severe Status Asthmaticus
Chest, May 1, 2001; 119(5): 1480 - 1488.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
H. W. Kelly
The Management of Acute Severe Asthma
Journal of Pharmacy Practice, April 1, 2001; 14(2): 91 - 107.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
M. Shannon
Life-Threatening Events After Theophylline Overdose: A 10-Year Prospective Analysis
Arch Intern Med, May 10, 1999; 159(9): 989 - 994.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Z. M. N. Quezado, W. D. Hoffman, S. M. Banks, R. L. Danner, P. Q. Eichacker, G. M. Susla, and C. Natanson
Increasing Doses of Pentoxifylline as a Continuous Infusion in Canine Septic Shock
J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 107 - 113.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child.Home page
M. Yung and M. South
Randomised controlled trial of aminophylline for severe acute asthma
Arch. Dis. Child., November 1, 1998; 79(5): 405 - 410.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
A. J. Pesce, M. Rashkin, and U. Kotagal
Standards of laboratory practice: theophylline and caffeine monitoring
Clin. Chem., May 1, 1998; 44(5): 1124 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. F. Lemanske Jr and W. W. Busse
Asthma
JAMA, December 10, 1997; 278(22): 1855 - 1873.
[Abstract] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
J. A. Everett
Alternatives to Standard Status Asthmaticus Therapy
Journal of Pharmacy Practice, June 1, 1997; 10(3): 186 - 199.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
J. P. Bien, M. D. Bloom, R. L. Evans, B. Specker, and K. P. O'Brien
Intravenous Theophylline in Pediatric Status Asthmaticus: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
Clinical Pediatrics, September 1, 1995; 34(9): 475 - 481.
[Abstract] [PDF]

Home page
 BMJHome page
S A McKenzie
Aminophylline in the hospital treatment of children with acute asthma
BMJ, May 28, 1994; 308(6941): 1384 - 1384.
[Full Text]

Home page
 JWatch GeneralHome page
MORE DOUBTS ABOUT AMINOPHYLLINE IN KIDS
Journal Watch (General), March 11, 1994; 1994(311): 2 - 2.
[Full Text]